Sansure Biotech (SHSE:688289) Change In Inventory: ¥ Mil (TTM As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Sansure Biotech Inc SHSE:688289

68 GF Score

Price ¥16.53

GF Value ¥21.80

Valuation Modestly Undervalued

7 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Sansure Biotech Change In Inventory?

Sansure Biotech SHSE:688289 +3.05% 68 Change In Inventory is ¥ Mil as of Jun. 2026. GuruFocus rates SHSE:688289 with a GF Score™ of 68/100 and a GF Value™ of ¥21.80 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Sansure Biotech's change in inventory for the quarter that ended in Jun. 2026 was ¥ Mil. It means Sansure Biotech's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Sansure Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was ¥-10 Mil. It means Sansure Biotech's inventory increased by ¥10 Mil from Dec. 2024 to Dec. 2025 .

Sansure Biotech's Total Inventories for the quarter that ended in Jun. 2026 was ¥451 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sansure Biotech's Days Inventory for the quarter that ended in Jun. 2026 was 237.15.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sansure Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.38.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sansure Biotech's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.13.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Sansure Biotech (SHSE:688289) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sansure Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	447.25667788	/	172.091865365	*	365 / 4
	=	237.15

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sansure Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	172.091865365	/	447.25667788
	=	0.38

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sansure Biotech's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	447.25667788	/	396.97250304
	=	1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sansure Biotech Change In Inventory Related Terms

Sansure Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Sansure Biotech's Change In Inventory can be seen below:

Sansure Biotech Change In Inventory Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-93.03

-282.10

-78.30

36.46

-10.31

Sansure Biotech Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

68GF Score

Sansure Biotech Inc SHSE:688289

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Sansure Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥ Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of ¥ Mil mean?

Sansure Biotech (SHSE:688289) has a Change In Inventory of ¥ Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sansure Biotech and its competitors.

Is Sansure Biotech's Change In Inventory too high?

Sansure Biotech's current Change In Inventory is ¥ Mil. Overall, Sansure Biotech has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Sansure Biotech's Change In Inventory compare to ISRG and BDX?

Sansure Biotech's Change In Inventory of ¥ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Medical Devices & Instruments company?

A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sansure Biotech and its competitors. Sansure Biotech's current Change In Inventory is ¥ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sansure Biotech stock overvalued right now?

Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.80, compared to a current price of ¥16.53 — trading 24.2% below its estimated fair value. The current Change In Inventory is ¥ Mil. Sansure Biotech's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Change In Inventory is ¥ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sansure Biotech (SHSE:688289) Overvalued in 2026?

Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued. The current stock price of ¥16.53 is trading 24.2% below its estimated GF Value™ of ¥21.80. GuruFocus considers Sansure Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688289:

Change In Inventory: ¥ Mil
GF Value™: ¥21.80 vs. price of ¥16.53 (24.2% below fair value)
GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →